ERBB2 and neoplasm: The reason for the obvious increase in PD-L1 in ERBB2-overexpressing gastric cancer is that STAT3 in the ERBB2 pathway and the ERBB2d16 pathway can directly increase the expression of PD-L1 in tumor tissue, as reported (31–33).